From:"Johnson, Laura"   
Subject:[NMusers] NONMEM Add-On Software Commercially Released  
Date:Fri, February 1, 2002 5:04 pm  

GloboMax* LLC (GloboMax), a leading provider of scientific, regulatory, and
technology solutions to the pharmaceutical and biotechnology industry,
announced the commercial release of PDx-PopTM software to facilitate
population pharmacokinetic and pharmacodynamic modeling and analysis.
Seamlessly integrating with NONMEM* and other existing software tools,
PDx-Pop expedites modeling using pre- and post-processing tools, accessible
through a user-friendly interface.
"Development of PDx-Pop began over two years ago as an internal tool, to
optimize and expedite our work with NONMEM*, the 'gold standard' in
Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic modeling,"
comments David Young, Pharm.D., Ph.D., President and CEO of GloboMax. "With
our recent acquisition of exclusive licensing rights to NONMEM, we are able
to offer the two products together, delivering optimum flexibility,
increased efficiency and added functionality while maintaining a high
standard of scientific excellence."

For more details about PDx-Pop:

To view full commercial press release:

PDx by GloboMaxTM
7250 Parkway Drive, Suite 430, Hanover, MD 21076 USA
Direct 410.782.2700 Main 410.712.9500 Fax 410.712.0737